CVS' Shoddy Shipping Ruined Arthritis Drug, Suit Says

Law360, New York (February 3, 2017, 6:18 PM EST) -- A CVS Health unit was hit with a proposed class action in California federal court on Thursday, alleging that the firm knowingly failed to ensure the arthritis drug Enbrel and others were kept at a safe temperature during shipping.

Named plaintiff B. Amburgey alleges in a complaint filed on Thursday in California's Central District that pharmacy benefits manager Caremark Health LLC violated California law by failing to ensure specialty drugs were kept within refrigerated but liquid state during shipping.

"Although Caremark is keenly aware of the specific temperature requirements," the complaint states, "Caremark does not have adequate policies and procedures in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!